August 2026– date –
-
AI Drug Discovery Reshapes Early Pharma Pipeline: Accelerates Target ID & Hit Generation to De-risk Late-Stage Failures
Converge Bio Unknown Overview AI-driven drug discovery is primarily impacting the early stages of the pharmaceutical pipeline, such as target identification and hit generation, by significantly accelerating processes that traditionally r... -
AI Drug Development Shifts to Clinical Validation Efficiency with Over 170 AI-Designed Molecules in Trials
Biology Digital News Unknown Overview The AI-driven pharmaceutical sector is reorienting its strategy from rapid drug discovery to enhancing clinical validation efficiency and pipeline quality, with over 170 AI-designed molecules now in ... -
AI-Designed Drugs Achieve 80-90% Phase 1 Success in Lung Cancer, Doubling Market Entry Probability
OncLive USA Overview AI-designed drugs are exhibiting remarkably high Phase 1 success rates of 80-90%, potentially doubling the probability of market entry compared to historical benchmarks. In lung cancer, AI tools show early promise ac... -
AI Accelerates Next-Gen Drug Design: From De Novo Protein Creation to Optimized Clinical Trials
SiTech Blog (MIT Technology Review analysis) USA Overview Artificial intelligence is revolutionizing drug discovery by enhancing every stage from protein structure prediction to clinical trial optimization. Generative models like RFdiffu... -
European EV Demand and US BESS Drive LG Energy Solution’s Q2 Profit Turnaround, Solid-State Battery Pilot Line Forthcoming
Energy-Storage.news South Korea Overview LG Energy Solution returned to profitability in Q2 2026, attributing its success to increased EV cell demand in Europe and robust Battery Energy Storage System (BESS) sales in the U.S. The company... -
LG Energy Solution Returns to Profit in Q2, Prepares Dry Electrode Pilot Line for Solid-State Batteries in H2 2026
Investing.com South Korea Overview LG Energy Solution announced a return to profitability in Q2 2026, driven by strong performance in its Energy Storage System (ESS) business. The company revealed plans to prepare a dry electrode process... -
SK On and Factorial Energy Partner to Industrialize Solid-State Batteries, Leveraging Existing Production Facilities
Pluang South Korea and USA Overview SK On and Factorial Energy have signed an MOU to jointly assess the feasibility of manufacturing Factorial's advanced solid-state battery technology within SK On's global lithium-ion battery production... -
SK On and Factorial Energy Ink MOU to Explore Solid-State Battery Manufacturing, Eyeing Existing Facilities for Mass Production
The Elec Inc. South Korea Overview SK On has signed an MOU with U.S. solid-state battery developer Factorial Energy for manufacturing collaboration on next-generation solid-state batteries. The partnership aims to jointly assess if Facto... -
French ITEN Launches “SOLIMED” Project for High-Capacity Solid-State Batteries in Class III Implantable Medical Devices: Targeting 600Wh/L and 20-Minute Fast Charging
Power Electronics News France Overview French solid-state energy storage company ITEN announced "SOLIMED," a major development program under Europe's IPCEI Tech4Cure initiative, to adapt high-capacity solid-state battery technology for C... -
Factorial Energy Partners with Tulip Tech to Propel Solid-State Battery Tech into UAV Market
Disrupts USA and Netherlands Overview Factorial Energy has forged a strategic partnership with Dutch UAV battery integrator Tulip Tech, signaling a significant expansion of its solid-state battery technology beyond electric vehicles into...
